Figure S2 from Proteogenomic approaches for the identification of NF1/neurofibromin-depleted estrogen receptor positive breast cancers for targeted treatment

crossref(2023)

引用 0|浏览2
暂无评分
摘要

Figure S2. Binimetinib and fulvestrant inhibited the intended targets in the two PDXs that did not regress after treatment.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要